Evidence map›Paper›PMID 41040926›Full record

ArticleFrontiers in veterinary science2025

Duration of immunity against infectious rhinotracheitis and bovine viral diarrhea after vaccination in calves in southern region of Kazakhstan.

Yerbol Bulatov, Zhanna Sametova, Ruslan Abitayev, Asselya Kyrgyzbayeva, Abdurakhman Ussembay, Zhanat Kondibaeva, Zhanat Amanova, Sholpan Turyskeldy, Dariya Toktyrova, Dana Mazbayeva and 8 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in veterinary science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Yerbol BulatovLaboratory for Technologies of Cultivation of Microorganisms, Research Institute for Biological, Safety Problems, QazBioPharm, Guardeyskiy, Kazakhstan.
Zhanna SametovaLaboratory for Technologies of Cultivation of Microorganisms, Research Institute for Biological, Safety Problems, QazBioPharm, Guardeyskiy, Kazakhstan.
Ruslan AbitayevLaboratory for Technologies of Cultivation of Microorganisms, Research Institute for Biological, Safety Problems, QazBioPharm, Guardeyskiy, Kazakhstan.
Asselya KyrgyzbayevaLaboratory for Technologies of Cultivation of Microorganisms, Research Institute for Biological, Safety Problems, QazBioPharm, Guardeyskiy, Kazakhstan.
Abdurakhman UssembayLaboratory for Technologies of Cultivation of Microorganisms, Research Institute for Biological, Safety Problems, QazBioPharm, Guardeyskiy, Kazakhstan.
Zhanat KondibaevaLaboratory for Technologies of Cultivation of Microorganisms, Research Institute for Biological, Safety Problems, QazBioPharm, Guardeyskiy, Kazakhstan.
Zhanat AmanovaLaboratory for Technologies of Cultivation of Microorganisms, Research Institute for Biological, Safety Problems, QazBioPharm, Guardeyskiy, Kazakhstan.
Sholpan TuryskeldyLaboratory for Technologies of Cultivation of Microorganisms, Research Institute for Biological, Safety Problems, QazBioPharm, Guardeyskiy, Kazakhstan.
Dariya ToktyrovaLaboratory for Technologies of Cultivation of Microorganisms, Research Institute for Biological, Safety Problems, QazBioPharm, Guardeyskiy, Kazakhstan.
Dana MazbayevaLaboratory for Technologies of Cultivation of Microorganisms, Research Institute for Biological, Safety Problems, QazBioPharm, Guardeyskiy, Kazakhstan.
Kamshat ShorayevaLaboratory for Control of Technologies and Biopreparations, Research Institute for Biological Safety Problems, QazBioPharm, Guardeyskiy, Kazakhstan.
Kuanysh JekebekovLaboratory for Control of Technologies and Biopreparations, Research Institute for Biological Safety Problems, QazBioPharm, Guardeyskiy, Kazakhstan.
Kuandyk ZhugunissovLaboratory for Collection of Microorganisms, Research Institute for Biological Safety Problems, QazBioPharm, Guardeyskiy, Kazakhstan.
Kainar BarakbayevLaboratory for Technologies of Finished Forms of Biological Preparations, Research Institute for Biological Safety Problems, QazBioPharm, Guardeyskiy, Kazakhstan.
Aslan KerimbayevLaboratory for Monitoring of Infectious Diseases, Research Institute for Biological Safety Problems, QazBioPharm, Guardeyskiy, Kazakhstan.
Aralbek RsaliyevQazBioPharm, Astana, Kazakhstan.
Yergali AbduraimovQazBioPharm, Astana, Kazakhstan.
Alina KurmashevaLaboratory for Technologies of Cultivation of Microorganisms, Research Institute for Biological, Safety Problems, QazBioPharm, Guardeyskiy, Kazakhstan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Some of the most economically significant viral infections affecting cattle globally include infectious bovine rhinotracheitis (IBR) and bovine viral diarrhea (BVD). Both viruses cause a wide range of clinical consequences and significant economic losses. Recent serological surveillance in Kazakhstan showed that these infections persist despite commercial vaccines, underscoring the need for more effective, locally appropriate immunization protocols. This study aimed to evaluate the duration of immunity conferred by a developed associated inactivated emulsion vaccine against IBR (strain "R-93") and BVD (strain "Oregon C

Indexed as

bovine viral diarrheacalvesimmunityinfectious bovine rhinotracheitispreventionvaccine

Identifiers

PMID41040926
PMCPMC12487427

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.